Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $757M | $959M | $1.17B | $1.43B | $1.82B | $2.70B | $3.95B |
| Revenue growth | — | 26.7% | 21.7% | 22.8% | 27.2% | 48.3% | 46.1% |
| Operating income | -$29.5M | -$5.26M | -$178M | -$129M | -$128M | -$102M | $14.8M |
| Operating margin | -3.9% | -0.5% | -15.2% | -9.0% | -7.0% | -3.8% | 0.4% |
| Net income | -$44.7M | -$22.9M | -$195M | -$150M | -$148M | -$128M | -$724K |
| Net margin | -5.9% | -2.4% | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% |
| EPS (diluted) | -$0.33 | -$0.15 | -$1.14 | -$0.83 | -$0.79 | -$0.67 | $0.00 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.21M | $7.56M | -$78.8M | -$45.4M | -$59.2M | $34.8M | $140M |
| Capital expenditures | — | — | — | $23.8M | $36.0M | $41.4M | $26.8M |
| Free cash flow | — | — | — | -$69.2M | -$95.2M | -$6.65M | $113M |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $86.5M | $207M | $467M | $410M | $203M | $433M | $576M |
| Total assets | — | $339M | $631M | $634M | $592M | $782M | $1.07B |
| Total liabilities | — | $308M | $325M | $395M | $434M | $681M | $887M |
| Long-term debt | — | $144M | $151M | $161M | $162M | $321M | $323M |
| Shareholders' equity | -$78.7M | $30.6M | $306M | $238M | $157M | $99.9M | $179M |
| Retained earnings | — | -$380M | -$583M | -$732M | -$880M | -$1.01B | -$1.01B |
| Shares (wtd avg diluted) | — | 164M | 182M | 181M | 186M | 191M | 198M |
Every figure is extracted from Alignment Healthcare, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.